FRANKLIN LAKES, N.J., JULY 28, 2016 – BD(Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that R. Andrew “Andy” Eckert has been appointed to the company’s Board of Directors, effective Sept. 26, bringing the total number of directors to 13.
Mr. Eckert, 55, is the CEO of Valence Health, Inc., a health care information technology and services company that provides clinical integration, population health and value-based care solutions to the health care industry. Prior to Valence, Mr. Eckert was CEO of TriZetto Corp. prior to its acquisition by Cognizant Technology Solutions in November 2014. He has held CEO roles with multiple other companies, including CRC Health Group, Inc., Eclipsys Corporation, SumTotal Systems Inc. and ADAC Laboratories, Inc. He also serves as Chairman of the Board of Directors for Varian Medical Systems, Inc.
“Andy is a proven leader in the growing field of health care information technology, and we believe he will be a valuable contributor to the BD Board of Directors as we move deeper into the digital health space,” said Vincent A. Forlenza, chairman, CEO and president of BD.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.